Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.

 

News

July 13, 2011 – The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC Corp ...

Home July 13, 2011
Home
News

Home June 30, 2011
Home
Technology

 

June 15, 2011 – The U.S. Food and Drug Administration (FDA) said Maquet Datascope Corp. has issued a class I recall for ...

Home June 15, 2011
Home
News

June 14, 2011 – An initial animal study of a next-generation cardiac assist device for heart failure patients using a ...

Home June 14, 2011
Home
News

May 11, 2011 – The Impella percutaneously deployed ventricular assist device showed an overall average hospital charge ...

Home May 11, 2011
Home
Technology

May 3, 2011 – The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Maquet Cardiovascular’s ...

Home May 03, 2011
Home
News

April 19, 2011 – Promising new devices for mechanical circulatory support of children with heart defects or heart ...

Home April 19, 2011
Home
News

April 13, 2011 – The American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the ...

Home April 13, 2011
Home
Feature | Dave Fornell

April 8, 2011 — A transcatheter ventricular assist device performed better than intra-aortic balloon pumps (IABP), with ...

Home April 08, 2011
Home
News

March 28, 2011 – The Therapeutic Goods Administration (TGA) of Australia has approved the HeartWare Ventricular ...

Home March 28, 2011
Home
News

March 11, 2011 – Texas Children's has become the world's first pediatric hospital to complete the first phase of ...

Home March 11, 2011
Home
News

February 17, 2011 – On Jan. 15, after 864 days of life with an artificial heart, Charles Okeke received a dual ...

Home February 17, 2011
Home
News

January 27, 2011 – The U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption ...

Home January 27, 2011
Home
News

January 26, 2011 - The University of Michigan Cardiovascular Center and the University of Pittsburgh have been ...

Home January 26, 2011
Home
News

January 13, 2011 – HeartWare International has submitted a Pre-Market Approval (PMA) application to the U.S. Food ...

Home January 13, 2011
Home
Subscribe Now